Ann Rheum Dis: Clinical characteristics and outcomes of COVID-19 infection in patients with rheumatism

The study aims to explore differences in clinical manifestations and outcomes ofinfection sdisease2019 coronavirus (
COVID-19) in patients with rheumatism and non-rheumatisma comparative cohort study of patients infected with COVID-19 (confirmed by severe acute respiratory syndrome coronavirus 2 PCR) in the cooperative health care system in the Greater Boston area of Massachusetts from March 1 to April 8, 2020, compared to theof diagnosis based on age, sex, and COVID-19in a 1:2 ratioThe differences in population, clinical characteristics and outcomes of COVID-19 infection were analyzedThe main outcomes were hospitalization, intensive care, mechanical ventilation and mortalityidentified 52 cases of rheumatic disease infected with COVID-19 (average age 63 years; 69 per cent female) and matched 104 non-rheumatic controlsMost patients with rheumatism (39 cases, 75%) are treated withimmuno
inhibitorsThe symptoms of rheumatism and non-rheumatism are similar to those of laboratory testsThe proportion of hospitalizations in patients with rheumatism and non-rheumatism was similar (23 (44%) vs 42 (40%),, p-0.50), but the proportion of patients with rheumatism requiring intensive care and mechanical ventilation was higher (11 (48%) vs 7 (18%), multifactor or 3.11 (95% CI 1.07-9.05) The mortality rates were similar in the two groups (3 (6%) vs 4 (4), p.69 rheumatism patients infected with COVID-19 are more likely to require mechanical ventilation, but have similar clinical characteristics and hospitalization rates to non-rheumatoid patients These findings are important for people with rheumatism, but need further validation